Comparison of efficacy of allergy medications
Pro Research Analysisby 
Searched over 200M research papers
Efficacy of Allergy Medications: Intranasal Corticosteroids, Antihistamines, and Combination Therapies
Multiple studies show that all major allergy medications—intranasal corticosteroids (INCS), intranasal antihistamines (INAH), oral antihistamines, and sublingual immunotherapy tablets (SLIT)—significantly improve nasal symptoms compared to placebo in both seasonal and perennial allergic rhinitis. Among these, INCS consistently demonstrate the greatest improvement in total nasal symptom scores, followed closely by combination INCS/INAH therapies. Intranasal antihistamines and oral antihistamines are also effective, but to a lesser degree than INCS. SLIT-tablets provide moderate improvement, even when patients have access to additional symptom-relieving medications. Montelukast, a leukotriene receptor antagonist, shows the smallest effect among the commonly used options for allergic rhinitis 14.
Comparative Efficacy Among Intranasal Corticosteroids
When comparing different INCS for moderate-to-severe allergic rhinitis, no single product is universally superior. However, some studies rank mometasone furoate and fluticasone furoate as slightly more effective for seasonal allergic rhinitis, while budesonide is ranked highest for perennial allergic rhinitis. All INCS are generally well-tolerated, with acceptability similar to placebo .
Allergy Immunotherapy: Sublingual, Subcutaneous, and Oral Routes
Allergy immunotherapy, including subcutaneous (SCIT), sublingual (SLIT), and oral immunotherapy, is effective for a range of allergens. SCIT and SLIT are particularly effective for aeroallergens like pollen and house dust mites. SCIT may be more effective for house dust mite allergies but is associated with a longer treatment duration and more side effects. SLIT is safer and suitable for most allergens, while oral immunotherapy is especially effective for food allergies and is the preferred option for elderly patients due to its safety profile. Accelerated and enhanced-dose immunotherapy regimens are also effective and safe 68.
Combination Therapies: Immunotherapy Plus Biologics
Combining allergen-specific immunotherapy (AIT) with biologic medications further improves clinical outcomes in allergic rhinitis and asthma. This combination reduces the need for emergency medications, decreases severe nasal symptoms, and lowers the risk of serious adverse reactions compared to AIT or biologics alone. The safety profile of the combination is favorable, with no significant increase in local or general adverse effects .
Real-World Effectiveness and Patient Compliance
Long-term, real-world studies confirm that both SCIT and SLIT lead to sustained reductions in allergy medication use, especially when patients remain persistent with therapy. SLIT tablets, in particular, show durable benefits for up to seven years with very low rates of severe allergic reactions. In pediatric populations, rush immunotherapy (RIT) combined with a single dose of anti-IgE offers faster symptom relief, better compliance, and similar safety compared to conventional immunotherapy, without additional cost 67.
Over-the-Counter (OTC) Allergy Medications: Physician Preferences
Physicians tend to prefer OTC medications that are most effective for the specific symptoms presented. For allergic rhinitis and conjunctivitis, certain oral OTC medications are favored, while others are preferred for skin symptoms of allergic dermatitis. Some oral OTC medications are considered equally effective for both respiratory and skin symptoms, allowing for tailored recommendations based on individual patient needs .
Conclusion
Allergy medications—including INCS, antihistamines, SLIT, and immunotherapy—are effective for managing allergic rhinitis and related conditions. INCS generally provide the greatest symptom relief, while immunotherapy (especially when combined with biologics) offers long-term benefits and disease modification. The choice of medication should be guided by the specific allergy, patient preferences, safety considerations, and the need for rapid or long-term control of symptoms.
Sources and full results
Most relevant research papers on this topic